Close



Sep 7, 2023 12:00PM
Aug 21, 2023 09:15AM
Aug 4, 2023 01:43PM
Aug 2, 2023 08:30AM
Aug 2, 2023 08:30AM
Jul 28, 2023 08:30AM
Jul 28, 2023 08:30AM Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert
Jun 26, 2023 07:30AM
Jun 22, 2023 07:30AM
May 25, 2023 04:26PM
May 19, 2023 12:04PM
May 19, 2023 12:00PM
May 15, 2023 04:47PM
May 8, 2023 04:05PM Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
Mar 16, 2023 04:24PM
Mar 14, 2023 04:01PM
Mar 14, 2023 08:30AM
Mar 14, 2023 08:30AM
Feb 27, 2023 04:06PM
Feb 27, 2023 04:05PM
Feb 22, 2023 04:02PM Adamis Pharmaceuticals (ADMP) Announce Nasdaq Grants Request for Extension to Comply with Continued Listing Requirements
Feb 22, 2023 04:01PM
Nov 14, 2022 04:10PM
Nov 7, 2022 04:05PM
Oct 3, 2022 04:30PM
Oct 3, 2022 04:30PM
Sep 21, 2022 07:30AM
Sep 21, 2022 07:30AM Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects
Sep 12, 2022 04:09PM
Sep 12, 2022 04:05PM
Aug 12, 2022 05:00PM
Aug 10, 2022 04:02PM
Aug 8, 2022 07:30AM
Jul 29, 2022 08:00AM
Jul 29, 2022 07:31AM Adamis Pharmaceuticals (ADMP) Provides Update on Clinical Study Assessing Tempol for Treatment of COVID-19
Jul 29, 2022 07:30AM
Jul 21, 2022 07:31AM
Jul 21, 2022 07:30AM
Jun 1, 2022 08:10AM
Jun 1, 2022 08:00AM
May 26, 2022 04:07PM
May 26, 2022 04:05PM Adamis Appoints Vickie Reed to Board of Directors
May 18, 2022 05:00PM
May 16, 2022 04:36PM
May 16, 2022 04:35PM
May 9, 2022 05:56PM
Mar 31, 2022 04:49PM
Mar 31, 2022 04:14PM
Mar 31, 2022 04:14PM US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone Product
Mar 24, 2022 07:30AM

251,730 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All